Colby Souders
Urology · Kansas City, KSNPI 1083155592
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,891 of the $2,811 with a category attached, or 67.3%. 12 manufacturers reported payments, led by Medtronic at 58.9% of the total. Reporting peaked in 2023 at $1,441 and has fallen 91.7% since, to $119 in 2025. That places this record below the midpoint for urology clinicians in KS, where the typical reported total is $2,717.
Across 38 payments — averaging $73.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Caldera Medical, Inc$460
- Boston Scientific$371
- Axonics, Inc.$140
- Endo Pharmaceuticals Inc.$42
- Johnson & Johnson$36
- plus $108 from 6 others
What the payments were for
- Travel & lodging$67324%
- Food & beverage$1,89167%
- Education$2469%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 19 | $1,654 |
| Caldera Medical, Inc | 2 | $460 |
| Boston Scientific | 7 | $371 |
| Axonics, Inc. | 1 | $140 |
| Endo Pharmaceuticals Inc. | 2 | $42 |
| Johnson & Johnson | 1 | $36 |
| Neotract Inc. | 1 | $30 |
| Urgo Medical North America, LLC | 1 | $23 |
| Convatec Inc. | 1 | $15 |
| AbbVie | 1 | $14 |
| Coloplast | 1 | $14 |
| Antares Pharma, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,811 in reported general payments places this provider in the 50th percentile of 111 urology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 127 | $78,401 |
| GemtesaVibegron | 30 | $17,089 |
| Estradiol | 140 | $10,957 |
| EstringEstradiol | 13 | $6,970 |
| Trospium Chloride ErTrospium Chloride | 23 | $4,202 |
| ImvexxyEstradiol | 16 | $3,362 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 53 | $1,131 |
| Oxybutynin Chloride ErOxybutynin Chloride | 30 | $879 |
| Methenamine Hippurate | 13 | $870 |
| Clobetasol Propionate | 13 | $741 |
| Tamsulosin Hcl | 33 | $382 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 58 | $209 |
| Cephalexin | 19 | $78 |
| Levofloxacin | 18 | $57 |
Paid to pharmacies, not to this prescriber.
Other urology in Kansas City
- Wilson MolinaKansas City$239K
- Bristol WhilesKansas City$163K
- Jeffrey HolzbeierleinKansas City$78K
- Ahmad El-ArabiKansas City$55K
- David DucheneKansas City$33K
- Joshua BroghammerKansas City$24K
- William ParkerKansas City$20K
- John TaylorKansas City$9K
- Casey KowalikKansas City$8K
- Richard FantusKansas City$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.